Skip to main content

cefuroxime sodium (Ximaract®)

 

Status: Medicine does not meet criteria for AWMSG assessment

Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information.

Medicine details

Medicine name cefuroxime sodium (Ximaract®)
Formulation 50 mg powder for solution for injection
Reference number 3481
Indication

Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery. Consideration should be given to official guidance on the appropriate use of antibacterial agents, including guidance on antibiotic prophylaxis in eye surgery

Company Bausch & Lomb UK Ltd
BNF chapter Infections
Submission type N/A
Status Medicine does not meet criteria for AWMSG assessment
Date of issue 09/08/2017
Follow AWTTC: